Non-Drowsy Wal-Phed PE Triple Relief

Product NDC: 0363-0412
11-digit product format: 003630412
Labeler code: 0363
Product ID: 0363-0412_03fe3e16-311e-4910-aa5d-0be76a0aca1f
Type: HUMAN OTC DRUG
Nonproprietary name: Acetaminophen, Guaifenesin and Phenylephrine HCl
Dosage form: TABLET, FILM COATED
Route: ORAL
Labeler: Walgreen Company
Application: part341
Marketing category: OTC MONOGRAPH FINAL
Marketing start: 2005-08-06
Marketing end: 2019-12-06
Substance: ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE
Active strength: 325 mg/1; mg/1; mg/1
NDC exclude flag: No
Listing certified through: 0000-00-00
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 2 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Reporting period	Source date
excluded product	product	0363-0412		D	Discontinued by firm		2026-10-05
excluded package	package	0363-0412	0363-0412-08	D	Discontinued by firm		2026-10-05

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 24 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	0363-0412-08	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	0363-0412-08	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	0363-0412-08	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	0363-0412-08	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	0363-0412-08	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	0363-0412-08	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	0363-0412-08	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	0363-0412-08	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	0363-0412-08	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	0363-0412-08	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	0363-0412-08	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	0363-0412-08	`557ba5c1ecfa…`	`9c80585c8c6e…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0363-0412-08	EA - Each	0363-0412	cfabad07-1b0c-4fbe-80fb-4f3a30a9805d	1	2014-08-01

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
ACETAMINOPHEN	ACTIVE INGREDIENT	362O9ITL9D	NON-DROWSY WAL-PHED PE TRIPLE RELIEF (ACEETAMINOPHEN, GUAIFENESIN AND PHENYLEPHRINE HCL) TABLET [WALGREEN CO.]	2
GUAIFENESIN	ACTIVE INGREDIENT	495W7451VQ	NON-DROWSY WAL-PHED PE TRIPLE RELIEF (ACEETAMINOPHEN, GUAIFENESIN AND PHENYLEPHRINE HCL) TABLET [WALGREEN CO.]	2
PHENYLEPHRINE HYDROCHLORIDE	ACTIVE INGREDIENT	04JA59TNSJ	NON-DROWSY WAL-PHED PE TRIPLE RELIEF (ACEETAMINOPHEN, GUAIFENESIN AND PHENYLEPHRINE HCL) TABLET [WALGREEN CO.]	2
ACETAMINOPHEN	ACTIVE MOIETY	362O9ITL9D	NON-DROWSY WAL-PHED PE TRIPLE RELIEF (ACEETAMINOPHEN, GUAIFENESIN AND PHENYLEPHRINE HCL) TABLET [WALGREEN CO.]	2
GUAIFENESIN	ACTIVE MOIETY	495W7451VQ	NON-DROWSY WAL-PHED PE TRIPLE RELIEF (ACEETAMINOPHEN, GUAIFENESIN AND PHENYLEPHRINE HCL) TABLET [WALGREEN CO.]	2
PHENYLEPHRINE	ACTIVE MOIETY	1WS297W6MV	NON-DROWSY WAL-PHED PE TRIPLE RELIEF (ACEETAMINOPHEN, GUAIFENESIN AND PHENYLEPHRINE HCL) TABLET [WALGREEN CO.]	2
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	NON-DROWSY WAL-PHED PE TRIPLE RELIEF (ACEETAMINOPHEN, GUAIFENESIN AND PHENYLEPHRINE HCL) TABLET [WALGREEN CO.]	2
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	NON-DROWSY WAL-PHED PE TRIPLE RELIEF (ACEETAMINOPHEN, GUAIFENESIN AND PHENYLEPHRINE HCL) TABLET [WALGREEN CO.]	2
MALTODEXTRIN	INACTIVE INGREDIENT	7CVR7L4A2D	NON-DROWSY WAL-PHED PE TRIPLE RELIEF (ACEETAMINOPHEN, GUAIFENESIN AND PHENYLEPHRINE HCL) TABLET [WALGREEN CO.]	2
POLYETHYLENE GLYCOLS	INACTIVE INGREDIENT	3WJQ0SDW1A	NON-DROWSY WAL-PHED PE TRIPLE RELIEF (ACEETAMINOPHEN, GUAIFENESIN AND PHENYLEPHRINE HCL) TABLET [WALGREEN CO.]	2
POLYVINYL ALCOHOL	INACTIVE INGREDIENT	532B59J990	NON-DROWSY WAL-PHED PE TRIPLE RELIEF (ACEETAMINOPHEN, GUAIFENESIN AND PHENYLEPHRINE HCL) TABLET [WALGREEN CO.]	2
POVIDONES	INACTIVE INGREDIENT	FZ989GH94E	NON-DROWSY WAL-PHED PE TRIPLE RELIEF (ACEETAMINOPHEN, GUAIFENESIN AND PHENYLEPHRINE HCL) TABLET [WALGREEN CO.]	2
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	NON-DROWSY WAL-PHED PE TRIPLE RELIEF (ACEETAMINOPHEN, GUAIFENESIN AND PHENYLEPHRINE HCL) TABLET [WALGREEN CO.]	2
SODIUM STARCH GLYCOLATE TYPE A POTATO	INACTIVE INGREDIENT	5856J3G2A2	NON-DROWSY WAL-PHED PE TRIPLE RELIEF (ACEETAMINOPHEN, GUAIFENESIN AND PHENYLEPHRINE HCL) TABLET [WALGREEN CO.]	2
SUCRALOSE	INACTIVE INGREDIENT	96K6UQ3ZD4	NON-DROWSY WAL-PHED PE TRIPLE RELIEF (ACEETAMINOPHEN, GUAIFENESIN AND PHENYLEPHRINE HCL) TABLET [WALGREEN CO.]	2
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	NON-DROWSY WAL-PHED PE TRIPLE RELIEF (ACEETAMINOPHEN, GUAIFENESIN AND PHENYLEPHRINE HCL) TABLET [WALGREEN CO.]	2
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	NON-DROWSY WAL-PHED PE TRIPLE RELIEF (ACEETAMINOPHEN, GUAIFENESIN AND PHENYLEPHRINE HCL) TABLET [WALGREEN CO.]	2

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
362O9ITL9D	ACETAMINOPHEN	103-90-2	ACETAMINOPHEN
495W7451VQ	GUAIFENESIN	93-14-1	GUAIFENESIN
04JA59TNSJ	PHENYLEPHRINE HYDROCHLORIDE	61-76-7	PHENYLEPHRINE HYDROCHLORIDE

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
Walgreens 44-527C-TR-Delisted	Walgreen Company \| LNK International, Inc.	2017-11-28	HUMAN OTC DRUG LABEL	6

Non-Drowsy Wal-Phed PE Triple Relief

NDC auxiliary status#

Observed NDC auxiliary status history#

Reported adverse events (FAERS/openFDA)#

DailyMed Billing Units#

DailyMed Socrata Ingredients#

Related Records#

Related UNII Ingredients#

Related DailyMed Labels#